Stay updated on DSP-5336 in Relapsed AML Clinical Trial

Sign up to get notified when there's something new on the DSP-5336 in Relapsed AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DSP-5336 in Relapsed AML Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-30T13:59:00.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-04-23T08:27:26.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has been updated to include new drug names and a revised interventional model description, while significant details about the previous study on Enzomenib have been removed.
    Difference
    36%
    Check dated 2025-04-16T01:48:45.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new study of DSP-5336 in relapsed/refractory acute leukemia, with significant changes in study details, including the addition of new locations and contacts for patient enrollment, as well as updated inclusion criteria for participants.
    Difference
    98%
    Check dated 2025-04-08T20:27:42.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.3%
    Check dated 2025-04-01T15:38:47.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-25T13:07:29.000Z thumbnail image

Stay in the know with updates to DSP-5336 in Relapsed AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DSP-5336 in Relapsed AML Clinical Trial page.